BioLineRx Ltd (BLRX) — Net Asset Quality Index
BioLineRx Ltd (BLRX) has a Net Asset Quality Index of 49.6% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $33.48 Million minus total liabilities of $16.86 Million yields net assets of $16.62 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read BioLineRx Ltd (BLRX) financial obligations for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
BioLineRx Ltd Net Asset Quality Index Over Time (2008–2025)
This chart shows how BioLineRx Ltd's Net Asset Quality Index has evolved across 18 annual periods from 2008 to 2025. As of June 2026, the index stands at 49.6%, representing net assets of $16.62 Million against total assets of $33.48 Million USD. For live market cap and overall valuation, see BioLineRx Ltd market cap and net worth.
Annual Net Asset Quality Index for BioLineRx Ltd (2008–2025)
The table below presents the year-by-year Net Asset Quality Index for BioLineRx Ltd from 2008 to 2025, covering 18 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check BLRX PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 57.1% | $23.34 Million | $40.90 Million | $17.56 Million | ▲ +22.5 pp |
| 2024 | 34.6% | $13.46 Million | $38.91 Million | $25.45 Million | ▲ +13.9 pp |
| 2023 | 20.7% | $13.22 Million | $63.92 Million | $50.70 Million | ▼ -45.9 pp |
| 2022 | 66.6% | $50.84 Million | $76.38 Million | $25.54 Million | ▼ -17.1 pp |
| 2021 | 83.7% | $68.09 Million | $81.39 Million | $13.30 Million | ▲ +37.1 pp |
| 2020 | 46.6% | $22.03 Million | $47.29 Million | $25.26 Million | ▼ -15.7 pp |
| 2019 | 62.3% | $33.38 Million | $53.57 Million | $20.19 Million | ▼ -11.2 pp |
| 2018 | 73.5% | $41.32 Million | $56.23 Million | $14.91 Million | ▼ -13.3 pp |
| 2017 | 86.7% | $52.88 Million | $60.97 Million | $8.08 Million | ▼ -3.2 pp |
| 2016 | 90.0% | $35.03 Million | $38.94 Million | $3.91 Million | ▼ -2.8 pp |
| 2015 | 92.8% | $47.61 Million | $51.30 Million | $3.69 Million | ▲ +5.0 pp |
| 2014 | 87.8% | $31.77 Million | $36.17 Million | $4.40 Million | ▲ +29.3 pp |
| 2013 | 58.6% | $11.68 Million | $19.95 Million | $8.27 Million | ▼ -3.0 pp |
| 2012 | 61.6% | $14.97 Million | $24.31 Million | $9.34 Million | ▼ -15.2 pp |
| 2011 | 76.8% | $22.53 Million | $29.34 Million | $6.81 Million | ▼ -8.5 pp |
| 2010 | 85.3% | $37.26 Million | $43.66 Million | $6.40 Million | ▲ +11.3 pp |
| 2009 | 74.1% | $31.13 Million | $42.02 Million | $10.88 Million | ▲ +6.4 pp |
| 2008 | 67.7% | $20.75 Million | $30.64 Million | $9.89 Million | — |